| Clonidine ( 0.1 mg) |
Tablet (Extended Release) |
II (Paddle) with sinker |
50 |
Acid stage: 0.01 N HCl; Buffer stage: Phosphate Buffer, pH 7.0 |
Acid stage: 500; Buffer stage: 500 |
Acid stage: 1 and 2 hours; Buffer stage: 1, 2, 4, 6, 10, 14 and 16 hours |
2012/01/26 |
| Clonidine ( EQ. 0.17 mg and EQ. 0.26 mg) |
Tablet (Extended Release) |
II (Paddle) |
50 |
500 mL 0.1N HCl for the 1st hour, then add 400 mL 0.27M Sodium Phosphate (Dibasic) buffer solution |
Acid stage: 500; Buffer stage: 900 |
1, 2, 3, 6, 9, 12, 16, 20 and 24 hours |
2010/07/01 |
| Clonidine HCl |
Tablet |
|
|
Refer to USP |
|
|
2007/06/18 |
| Clonidine HCl (0.1 mg & 0.2 mg) |
Tablet (Extended Release) |
II (Paddle) with sinker |
50 |
Acid stage: 0.01 N HCl; Buffer stage: Phosphate Buffer, pH 7.0 |
Acid stage: 500; Buffer stage: 500 |
Acid stage: 1 and 2 hours; Buffer stage: 1, 2, 4, 6, 10, 14 and 16 hours |
2015/08/27 |
| Clonidine Hydrochloride |
Suspension, Extended Release |
II (Paddle) |
50 |
0.6 M KH2PO4 solution, pH 4.3 |
900 |
0.5, 1, 2, 3, 4, 6, 8, 12, 14, 16, 18 and 24 hours |
2025/06/23 |
| Clopidogrel Bisulfate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Clorazepate Dipotassium |
Tablet |
|
|
Refer to USP |
|
|
2013/01/31 |
| Clotrimazole |
Lozenge |
|
|
Refer to USP |
|
|
2008/10/06 |
| Clotrimazole |
Tablet (Vaginal) |
II (Paddle) |
50 |
0.1 N HCl |
900 |
10, 20, 30 and 45 |
2004/01/24 |
| Clozapine |
Tablet (Orally Disintegrating) |
II (Paddle |
50 RPM (12.5 mg, 25 mg and 100 mg); 75 RPM (150 mg and 200 mg) |
pH 4.5 Acetate Buffer |
900 |
5, 10, 15, 20, and 30 |
2011/06/09 |
| Clozapine |
Tablet |
|
|
Refer to USP |
|
|
2011/07/21 |
| Clozapine |
Suspension |
II (Paddle) |
50 |
Acetate Buffer (pH 4.0) |
900 |
5, 10, 15, 20 and 30 |
2015/05/28 |
| Cobicistat |
Tablet |
II (Paddle) |
75 |
50 mM Sodium Acetate Buffer, pH 4.5 |
900 |
5, 10, 15, 20 and 30 |
2015/08/27 |
| Cobicistat (Cobi)/ Darunavir Ethanolate (Drv) |
Tablet |
Cobi: II (Paddle): Drv: II (Paddle) |
Cobi: 75; Drv:75 |
Cobi: 0.05 M Citrate Phosphate Buffer, pH 4.2; Drv: 0.05 M Sodium Phosphate Buffer, pH 3.0, 2% Tween 20 |
Cobi: 900 mL; Drv: 900 mL |
Cobi: 5, 10, 15, 20 and 30; Drv: 10, 15, 20, 30 and 45 |
2016/10/20 |
| Cobicistat/Elvitegravir/ Emtricitabine/Tenofovir Alafenamide Fumarate |
Tablet |
II (Paddle) |
100 |
0.05 M sodium citrate buffer pH 5.5 containing 2.0% w/v polysorbate 80 |
1000 |
5, 10, 15, 20 and 30 |
2016/10/20 |
| Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate |
Tablet |
II (Paddle) with sinker |
100 |
0.01 N HCl with 2% w/w Polysorbate 80 |
1000 |
5, 10, 15, 20 and 30 |
2015/06/25 |
| Cobimetinib Fumarate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Codeine Sulfate |
Tablet |
|
|
Refer to USP |
|
|
2011/09/01 |
| Colchicine |
Capsule |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Colchicine |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |